Pfizer
PFE
PFE
2,665 hedge funds and large institutions have $136B invested in Pfizer in 2020 Q4 according to their latest regulatory filings, with 312 funds opening new positions, 664 increasing their positions, 1,688 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
5.87% less ownership
Funds ownership: 72.5% → 66.62% (-5.9%)
37% less funds holding in top 10
Funds holding in top 10: 102 → 64 (-38)
61% less repeat investments, than reductions
Existing positions increased: 664 | Existing positions reduced: 1,688
Holders
2,665
Holding in Top 10
64
Calls
$2.58B
Puts
$2.19B
Top Buyers
| 1 | +$186M | |
| 2 | +$172M | |
| 3 | +$149M | |
| 4 |
Bank of New York Mellon
New York
|
+$142M |
| 5 |
O
OrbiMed
New York
|
+$133M |
Top Sellers
| 1 | -$1.48B | |
| 2 | -$1.01B | |
| 3 | -$925M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$697M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$615M |